{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:12:39Z","timestamp":1793747559862,"version":"4.6.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.lpm.2025.104295","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T19:18:11Z","timestamp":1748546291000},"page":"104295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Genetic aspects of vascular malformations"],"prefix":"10.1016","volume":"54","author":[{"given":"Nicole","family":"Revencu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Coulie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence M.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miikka","family":"Vikkula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lpm.2025.104295_bib0001","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00006534-198203000-00002","article-title":"Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics","volume":"69","author":"Mulliken","year":"1982","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.lpm.2025.104295_bib0002","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/CIRCRESAHA.121.318145","article-title":"Genetic basis and therapies for vascular anomalies","volume":"129","author":"Queisser","year":"2021","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.lpm.2025.104295_bib0003","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1016\/j.jtha.2024.07.013","article-title":"Targeted treatments for vascular malformations: current state of the art","volume":"22","author":"Seront","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"21","key":"10.1016\/j.lpm.2025.104295_bib0004","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1056\/NEJMoa1213507","article-title":"Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ","volume":"368","author":"Shirley","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.lpm.2025.104295_bib0005","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10456-016-9538-1","article-title":"A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth","volume":"20","author":"Couto","year":"2017","journal-title":"Angiogenesis"},{"issue":"10","key":"10.1016\/j.lpm.2025.104295_bib0006","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1111\/ene.15452","article-title":"GNA11-mutated Sturge-Weber syndrome has distinct neurological and dermatological features","volume":"29","author":"Dompmartin","year":"2022","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.lpm.2025.104295_bib0007","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s13023-021-01929-8","article-title":"A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations","volume":"16","author":"Canaud","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.lpm.2025.104295_bib0008","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1086\/379793","article-title":"Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations","volume":"73","author":"Eerola","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1016\/j.lpm.2025.104295_bib0009","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/CIRCULATIONAHA.116.026886","article-title":"Germline loss-of-function mutations in EPHB4 cause a second form of capillary malformation-arteriovenous malformation (CM-AVM2) deregulating RAS-MAPK signaling","volume":"136","author":"Amyere","year":"2017","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.lpm.2025.104295_bib0010","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archderm.144.7.873","article-title":"Association of localized intravascular coagulopathy with venous malformations","volume":"144","author":"Dompmartin","year":"2008","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.lpm.2025.104295_bib0011","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0092-8674(00)81814-0","article-title":"Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2","volume":"87","author":"Vikkula","year":"1996","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.lpm.2025.104295_bib0012","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ng.272","article-title":"Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations","volume":"41","author":"Limaye","year":"2009","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.lpm.2025.104295_bib0013","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jid.2016.07.034","article-title":"Blue rubber bleb nevus (BRBN) syndrome is caused by somatic TEK (TIE2) mutations","volume":"137","author":"Soblet","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.lpm.2025.104295_bib0014","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.ajhg.2015.11.011","article-title":"Somatic activating PIK3CA mutations cause venous malformation","volume":"97","author":"Limaye","year":"2015","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.lpm.2025.104295_bib0015","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1086\/339492","article-title":"Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (\u201cglomangiomas\u201d)","volume":"70","author":"Brouillard","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.lpm.2025.104295_bib0016","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ajhg.2017.01.018","article-title":"Mutations are associated with extracranial arteriovenous malformation","volume":"100","author":"Couto","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.lpm.2025.104295_bib0017","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/jdv.18046","article-title":"Somatic mutational landscape of extracranial arteriovenous malformations and phenotypic correlations","volume":"36","author":"El Sissy","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11\u201312","key":"10.1016\/j.lpm.2025.104295_bib0018","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00439-019-02072-y","article-title":"Arteriovenous malformation associated with a HRAS mutation","volume":"138","author":"Konczyk","year":"2019","journal-title":"Hum Genet"},{"issue":"4","key":"10.1016\/j.lpm.2025.104295_bib0019","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10456-024-09934-8","article-title":"D\u00f6ring Y. Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibition","volume":"27","author":"Kapp","year":"2024","journal-title":"Angiogenesis"},{"issue":"3","key":"10.1016\/j.lpm.2025.104295_bib0020","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-0037-1604298","article-title":"Angioarchitecture of hereditary arteriovenous malformations","volume":"34","author":"Burrows","year":"2017","journal-title":"Semin Intervent Radiol"},{"issue":"7","key":"10.1016\/j.lpm.2025.104295_bib0021","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/humu.20746","article-title":"Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations","volume":"29","author":"Revencu","year":"2008","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.lpm.2025.104295_bib0022","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.blre.2010.07.001","article-title":"Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment","volume":"24","author":"Shovlin","year":"2010","journal-title":"Blood Rev"},{"issue":"9","key":"10.1016\/j.lpm.2025.104295_bib0023","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/jmg.2007.048934","article-title":"The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management","volume":"44","author":"Tan","year":"2007","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.lpm.2025.104295_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2014.12.069","article-title":"Lymphatic and other vascular malformative\/overgrowth disorders are caused by somatic mutations in PIK3CA","volume":"166","author":"Luks","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.lpm.2025.104295_bib0025","doi-asserted-by":"crossref","unstructured":"Zenner K., Jensen D.M., Dmyterko V., Shivaram G.M., Myers C.T., Paschal C.R., et al. Somatic activating BRAF variants cause isolated lymphatic malformations. HGG Adv. 2022;3(2):100101. https:\/\/doi.org\/10.1016\/j.xhgg.2022.100101.","DOI":"10.1016\/j.xhgg.2022.100101"},{"issue":"1","key":"10.1016\/j.lpm.2025.104295_bib0026","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCRESAHA.121.318142","article-title":"Lymphatic malformations: genetics, mechanisms and therapeutic strategies","volume":"129","author":"M\u00e4kinen","year":"2021","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.lpm.2025.104295_bib0027","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1084\/jem.20181353","article-title":"Somatic activating mutations in PIK3CA cause generalized lymphatic anomaly","volume":"216","author":"Rodriguez-Laguna","year":"2019","journal-title":"J Exp Med"},{"issue":"15","key":"10.1016\/j.lpm.2025.104295_bib0028","article-title":"KRAS-driven model of Gorham-Stout disease effectively treated with trametinib","volume":"6","author":"Homayun-Sepehr","year":"2021","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.lpm.2025.104295_bib0029","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/s10038-020-0794-y","article-title":"A somatic activating KRAS variant identified in an affected lesion of a patient with Gorham-Stout disease","volume":"65","author":"Nozawa","year":"2020","journal-title":"J Hum Genet"},{"issue":"7","key":"10.1016\/j.lpm.2025.104295_bib0030","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/s41436-018-0390-0","article-title":"A somatic activating NRAS variant associated with kaposiform lymphangiomatosis","volume":"21","author":"Barclay","year":"2019","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.lpm.2025.104295_bib0031","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/s41591-023-02364-x","article-title":"Genomic profiling informs diagnoses and treatment in vascular anomalies","volume":"29","author":"Li","year":"2023","journal-title":"Nat Med"},{"issue":"18","key":"10.1016\/j.lpm.2025.104295_bib0032","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1093\/hmg\/ddy218","article-title":"Pathogenic variant in EPHB4 results in central conducting lymphatic anomaly","volume":"27","author":"Li","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"634","key":"10.1016\/j.lpm.2025.104295_bib0033","doi-asserted-by":"crossref","first-page":"eabm4869","DOI":"10.1126\/scitranslmed.abm4869","article-title":"Pathogenic variants in MDFIC cause recessive central conducting lymphatic anomaly with lymphedema","volume":"14","author":"Byrne","year":"2022","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.lpm.2025.104295_bib0034","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41572-021-00309-7","article-title":"Primary lymphoedema","volume":"7","author":"Brouillard","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.lpm.2025.104295_bib0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13023-021-01898-y","article-title":"Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations","volume":"16","author":"Brouillard","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.lpm.2025.104295_bib0036","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.63883","article-title":"Non-hotspot PIK3CA variants have higher variant allele frequency and are more common in syndromic vascular malformations","volume":"197","author":"Andreoti","year":"2025","journal-title":"Am J Med Genet A."},{"issue":"1","key":"10.1016\/j.lpm.2025.104295_bib0037","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/GIM.0b013e31802d8373","article-title":"Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-italian HHT network","volume":"9","author":"Lesca","year":"2007","journal-title":"Genet Med"},{"key":"10.1016\/j.lpm.2025.104295_bib0038","series-title":"GeneReviews\u00ae [Internet]","article-title":"Hereditary hemorrhagic telangiectasia","author":"McDonald","year":"1993"},{"issue":"1","key":"10.1016\/j.lpm.2025.104295_bib0039","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/cge.13204","article-title":"Splice-site mutations in VEGFC cause loss of function and Nonne-Milroy-like primary lymphedema","volume":"94","author":"Fastr\u00e9","year":"2018","journal-title":"Clin Genet"},{"issue":"12","key":"10.1016\/j.lpm.2025.104295_bib0040","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/humu.22431","article-title":"RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation","volume":"34","author":"Revencu","year":"2013","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.lpm.2025.104295_bib0041","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ajhg.2012.12.017","article-title":"Somatic uniparental isodisomy explains multifocality of glomuvenous malformations","volume":"92","author":"Amyere","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.lpm.2025.104295_bib0042","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/hmg\/ddn430","article-title":"Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis","volume":"18","author":"Akers","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.lpm.2025.104295_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2015.00001","article-title":"Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era","volume":"6","author":"McDonald","year":"2015","journal-title":"Front Genet"},{"issue":"6","key":"10.1016\/j.lpm.2025.104295_bib0044","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/ejhg.2009.26","article-title":"Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics","volume":"17","year":"2009","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"10.1016\/j.lpm.2025.104295_bib0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13023-024-03196-9","article-title":"Assessment of gene-disease associations and recommendations for genetic testing for somatic variants in vascular anomalies by VASCERN-VASCA","volume":"19","author":"Revencu","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.lpm.2025.104295_bib0046","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41436-020-00943-8","article-title":"Cell-free DNA as a diagnostic analyte for molecular diagnosis of vascular malformations","volume":"23","author":"Zenner","year":"2021","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.lpm.2025.104295_bib0047","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10048-007-0109-x","article-title":"Different spectra of genomic deletions within the CCM genes between Italian and American CCM patient cohorts","volume":"9","author":"Liquori","year":"2008","journal-title":"Neurogenetics"},{"issue":"1","key":"10.1016\/j.lpm.2025.104295_bib0048","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/jmedgenet-2019-106024","article-title":"RASA1 mosaic mutations in patients with capillary malformation-arteriovenous malformation","volume":"57","author":"Revencu","year":"2020","journal-title":"J Med Genet"},{"issue":"21","key":"10.1016\/j.lpm.2025.104295_bib0049","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.173095","article-title":"Preliminary results of the European multicentric phase III trial regarding sirolimus in slow-flow vascular malformations","volume":"8","author":"Seront","year":"2023","journal-title":"JCI Insight"},{"issue":"7711","key":"10.1016\/j.lpm.2025.104295_bib0050","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41586-018-0217-9","article-title":"Targeted therapy in patients with PIK3CA-related overgrowth syndrome","volume":"558","author":"Venot","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.lpm.2025.104295_bib0051","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s44161-022-00080-2","article-title":"Case report study of thalidomide therapy in 18 patients with severe arteriovenous malformations","volume":"1","author":"Boon","year":"2022","journal-title":"Nat Cardiovasc Res"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498225000284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498225000284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T11:57:39Z","timestamp":1756209459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498225000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0755498225000284"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2025.104295","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic aspects of vascular malformations","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2025.104295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104295"}}